Broadly neutralizing antibodies (bNAbs) possess favorable safety, and passive
immunization using these can prevent or control human immunodeficiency virus type 1 (HIV …

In the past two decades, there has been an explosion in the discovery of HIV-1 broadly
neutralizing antibodies (bnAbs) and associated vaccine strategies to induce them. This …

The recent discoveries of broadly potent neutralizing human monoclonal antibodies
represent a new generation of antiretrovirals for the treatment and prophylaxis. Antibodies …

Although antibodies can be elicited by HIV-1 infection or immunization, those that are
broadly neutralizing (bnAbs) are undetectable in most individuals, and when they do arise in …

Background: Broadly neutralizing antibodies (bnAbs) are a promising approach for HIV-1
prevention. In the only bnAb HIV prevention efficacy studies to date, the Antibody Mediated …

Promptly after primoinfection, HIV generates a pool of infected cells carrying transcriptionally
silent integrated proviral DNA, the HIV-1 reservoir. These cells are not cleared by combined …

Induction of broadly neutralizing antibodies (bnAbs) is considered the holy grail for a
preventive human immunodeficiency virus (HIV) vaccine, but four decades into the HIV …

Broadly neutralizing antibodies (bNAbs) against the HIV-1 envelope glycoprotein (Env)
suppress viremia in animal models of HIV-1 and humans. To achieve potent activity without …

The use of broadly neutralizing antibodies (bNAbs) as a cure-related research strategy for
human immunodeficiency virus (HIV) has gained attention from the scientific community …

Broadly neutralizing antibodies (bNAbs) offer promising opportunities for preventing HIV-1
infection. The protection mechanisms of bNAbs involve the Fc domain, as well as their Fab …